MyFinsight
Home
About
Contact
Download
Download image
Grant income
$864,014
Interest income
$257,913
Net loss
-$8,484,763
Other income, net
$738,718
Interest expense
$382,014
Other
-$1,195
Loss from operations
-$9,223,481
Total operating
expenses
$9,223,481
General and
administrative
$4,923,540
Research and development
$4,299,941
Back
Back
Income Statement
source: myfinsight.com
Anebulo Pharmaceuticals, Inc. (ANEB)
Anebulo Pharmaceuticals, Inc. (ANEB)